Mindpeak Prostate H&E is an advanced software module designed for the automated analysis of digital histopathology images of prostate needle biopsies. It identifies areas suspicious for cancer and grades malignancies using the Gleason scoring system. This tool enhances the efficiency and accuracy of prostate cancer detection and grading, providing pathologists with reliable and reproducible results.
RapidCDI™ is an AI-powered solution designed to transform clinical documentation into precise risk scores at the point of care, thereby enhancing value-based care initiatives. By automating the risk adjustment process, RapidCDI reduces provider burden, improves coding efficiency, and elevates quality measures. Its seamless integration with over 80 Electronic Health Records (EHR) systems ensures swift deployment, delivering tangible results in weeks rather than months.
Adonis AI Agents is an advanced solution designed to enhance revenue cycle management (RCM) by integrating intelligent automation with proactive problem-solving. This platform enables RCM teams to streamline workflows, improve financial performance, and reduce operational costs with exceptional precision.
AI Xpert is Dot Compliance's pioneering, vendor-agnostic decision guidance system designed to enhance quality and compliance management across life sciences organizations. By centrally analyzing data from various systems of record—including ERP, Clinical, R&D, and QMS—AI Xpert seamlessly integrates with platforms like Salesforce to uncover hidden risks, identify non-compliance patterns, and proactively alert users to potential issues before they escalate.
QP-Insights® is an advanced, cloud-based platform designed for the comprehensive management, storage, and analysis of large-scale multi-omics data and medical images. Tailored for clinical studies and research projects, it enables users to enhance their analytical capabilities by integrating imaging data with processed electronic health records (EHR), facilitating the extraction of new predictive models and biomarkers.
QP-Prostate® is an advanced AI-powered software solution designed to enhance prostate MRI analysis by automating critical processes such as prostate segmentation and lesion detection. Developed by Quibim, this tool addresses the increasing demand for accurate and efficient prostate cancer diagnostics, streamlining radiologists' workflows and improving patient care.
Navina's AI-powered Risk Adjustment software enhances value-based care by providing clinicians with accurate, real-time insights into patients' health statuses and Risk Adjustment Factor (RAF) scores. By analyzing comprehensive patient data—including claims, health information exchanges (HIE), and unstructured electronic health record (EHR) data such as notes and imaging—Navina ensures that no condition is overlooked. This integration within existing EHR systems streamlines workflows, reduces ad
Compliance Xpand is a comprehensive electronic Quality Management System (eQMS) designed to scale with your business as it grows. It offers ready-to-deploy add-on modules that seamlessly integrate into your existing quality platform, enabling the management of cross-functional quality and compliance processes. This solution is particularly beneficial for life sciences organizations seeking to unify their quality management ecosystem and foster a culture of quality throughout the organization.
BioXcel Therapeutics is a biopharmaceutical company leveraging artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology. Their lead product, IGALMI™ (dexmedetomidine) sublingual film, is approved for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Additionally, BioXcel is investigating BXCL501, an orally dissolving film formulation of dexmedetomidine, for the acute treatment of agitation associated with
H-Optimus-1 is a state-of-the-art foundation model developed by Bioptimus, designed to revolutionize histological analysis in biomedical research and diagnostics. By leveraging a vast and diverse dataset of over one million whole-slide images from more than 800,000 patients, H-Optimus-1 captures complex histological patterns across various tissue types and pathological conditions. This extensive training enables the model to generate powerful embeddings that serve as a robust backbone for a wide
QP-Lung® is an advanced AI-driven solution designed to enhance the analysis of lung cancer heterogeneity and predict clinical outcomes using standard-of-care (SoC) CT scans. By integrating with existing diagnostic techniques, QP-Lung® classifies tumor mutational status, forecasts responses to immune checkpoint inhibitors, and estimates overall survival rates from baseline CT images.
Mindpeak Esophagus PD-L1 is an advanced software solution designed for the automated analysis of digital histopathology images from PD-L1-stained esophageal squamous cell carcinoma tissue samples. This stand-alone application streamlines the detection and quantification of PD-L1 expression, providing pathologists with rapid and accurate tumor proportion scores (TPS). By differentiating between stained (tumor positive) and unstained (tumor negative) cells, the software enhances the precision of i
deepcOS® Hub is a centralized AI management platform designed to streamline radiology operations by providing unified access to a comprehensive suite of tools for radiologists, IT administrators, and AI developers. It integrates seamlessly with existing hospital IT systems, enabling efficient deployment, monitoring, and evaluation of AI solutions within radiology workflows.
The AI Evaluator, a component of deepcOS®, is a comprehensive platform designed to assist radiology departments in assessing and comparing various AI solutions before integration into clinical workflows. It enables users to explore AI applications using their own data, ensuring that selected solutions align with specific clinical needs and performance expectations.
SmarterDx is a clinical AI platform designed to enhance hospital revenue integrity and improve quality metrics by analyzing 100% of patient charts. By leveraging proprietary algorithms, SmarterDx identifies every diagnosis, including those not documented, enabling hospitals to capture net new revenue and achieve a 5:1 return on investment from day one.
HawkAI for Veterinarians is an advanced deep learning algorithm designed to enhance MRI imaging in veterinary practices. By integrating seamlessly with existing MRI systems, HawkAI significantly reduces scan times and improves image clarity, enabling veterinarians to make more accurate diagnoses and provide better patient care. This cloud-based solution is compatible with all MRI manufacturers and systems, including older platforms, and operates effectively across a range of magnetic field stren
Pathos is a clinical-stage biotechnology company dedicated to revolutionizing drug development through advanced artificial intelligence (AI) technologies. By integrating extensive multimodal datasets with sophisticated AI models, Pathos aims to enhance the precision and efficiency of therapeutic development, particularly in oncology.
New Lantern is a cloud-native AI radiology suite designed to enhance radiologists' efficiency by automating key imaging and reporting workflows. By integrating advanced AI capabilities, New Lantern streamlines tasks such as volumetric measurements, report generation, and worklist management, allowing radiologists to focus more on diagnostic interpretation and patient care.
Dexa AI is an innovative platform that leverages artificial intelligence to provide users with direct access to expert knowledge from a diverse range of trusted professionals. By indexing and analyzing content from podcasts and videos, Dexa enables users to ask questions and receive precise answers sourced directly from these media, effectively transforming them into dynamic knowledge hubs.
Ezra offers an AI-powered, end-to-end cancer screening platform designed to detect cancer and over 500 other medical conditions through advanced imaging technologies. By integrating state-of-the-art artificial intelligence with comprehensive MRI scans, Ezra aims to make early cancer detection more accessible, efficient, and affordable.